处方阿片类药物使用与心力衰竭之间的关联:队列研究和门德尔随机化分析
Guang Hao1, Xia Chen2, Zhenger Fang2
1School of Public Health, Guangdong Pharmaceutical University, Guangzhou, China.
International journal of cardiology
|July 29, 2024
概括
处方阿片类药物使用 (POU) 显著增加了32%的心力衰竭 (HF) 的风险. 这项研究证实了POU和HF之间的因果关系,强调了需要对风险人群进行仔细监测的必要性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 遗传学 是一个遗传学.
背景情况:
- 处方阿片类药物使用 (POU) 与心血管疾病 (CVD) 有关.
- 在POU和心力衰竭 (HF) 之间的关联仍未得到充分研究.
- 这项研究调查了POU和HF之间的潜在因果关系.
研究的目的:
- 检查POU和HF之间的纵向关联.
- 使用孟德尔随机化 (MR) 评估POU和HF之间的潜在因果关系.
主要方法:
- 利用了来自健康和退休研究 (HRS) 和英国生物银行 (UK Biobank) 的队列数据.
- 使用两样 MR 分析与全基因组关联研究 (GWAS) 总结统计数据.
- 进行了敏感性分析,以检查型和异质性.
主要成果:
- 观察分析显示,POU用户中HF风险增加了32% (HR=1.32).
- 核磁共振分析表明,POU的遗传责任对HF风险增加的因果关系 (OR=1.16).
- 灵敏度分析表明一致的结果,没有显著的类或异质性.
结论:
- POU与发展HF的显著高风险有关.
- 这些发现为POU对心力衰竭的影响提供了新的见解.
- 需要进一步的研究来验证这些发现,并探索潜在的机制.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
Heart Failure Drugs: Inotropic Agents
555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555
Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Opioid Analgesics: Morphine and Other Natural Cogeners
210
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
210


